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The impact of naïve-precursor frequency on human virus-specific CD8 T cell immunodominance is not well
understood. Using a recently developed major histocompatibility complex (MHC) class I tetramer enrichment
protocol, we found a conserved hierarchy and a >10-fold difference in naïve-precursor frequencies across three
HLA-A2-restricted hepatitis C virus (HCV)-specific epitopes. Importantly, the NS31406 epitope with the highest
naïve-precursor frequency in healthy donors was also the most frequently targeted epitope in a large cohort of
chronically HCV-infected patients, both ex vivo and after in vitro stimulation. These results indicate for the first
time that immunodominance in a human viral infection is linked to naïve-precursor frequency.
CD8 T cells play an important role in the outcome of
human viral infections, including hepatitis C virus (HCV) in-
fection (23). Although viral pathogens encode thousands of
potentially immunogenic determinants, CD8 T cells recog-
nize and respond to only a very small fraction of these potential
viral epitopes. This phenomenon is called immunodominance.
Factors that contribute to CD8 T cell immunodominance
include antigen processing and presentation, abundance of
peptide-major histocompatibility complex class I (pMHCI)
molecules on antigen-presenting cells, and the number of naïve
T cells that express complementary T cell receptors (25). The
study of naïve antigen-specific CD8 T cell frequency as a
determinant of immunodominance has only recently become
possible through the use of improved pMHCI tetramer enrich-
ment protocols. Importantly, these studies, performed in dif-
ferent mouse models, have largely suggested that CD8 T cell
response magnitude is dictated by naïve-precursor frequency
(8, 16, 18). One recent study, however, performed in a mouse
model of influenza virus infection, suggested that T cell immu-
nodominance is determined instead by recruitment from the
available pool of epitope-specific precursors and the duration
of their continued expansion over the course of viral infection
(10). Thus far, the impact of naïve-precursor frequency on T
cell immunodominance has not been analyzed in human viral
infections. Recently, however, the group of Matthew Albert
reported a new strategy based on the combination of tetramer
staining, magnetic-bead enrichment, and multiparametric flow
cytometry (1). This experimental approach allowed for the first
time the detection and analysis of naïve human CD8 T cells
specific for different epitopes (1). The authors reported a
100-fold differences in naïve-precursor frequencies against
epitopes derived from MART1 (Melan-A), HIV, HCV, NY-
ESO-1, and cytomegalovirus (CMV) that were conserved
among individuals. Here, using the same novel approach, we
set out to determine whether immunodominance hierarchies
within HLA-A2-restricted HCV-specific CD8 T cell re-
sponses are linked to naïve-precursor frequency.
Precursor frequency of naïve HLA-A2-restricted hepatitis C
virus-specific CD8 T cells. In a first set of experiments, we
analyzed the naïve-precursor frequencies of CD8 T cells spe-
cific for three well-described HLA-A2-restricted HCV
epitopes (4, 13, 20) (Table 1) in seven healthy donors. The
analysis was limited to three epitopes only, because a major
limitation of the novel tetramer enrichment protocol for the
analysis of naïve CD8 T cells is the requirement for high
volumes of blood. We did not include the frequently recog-
nized HLA-A2-restricted NS31073 epitope in our analysis, since
CD8 T cell responses to this epitope may be influenced by
past exposure to influenza virus (22, 24). However, the cross-
reactivity between these viral epitopes is weak and mostly uni-
directional, e.g., CD8 T cells primed with the HCV epitope
can be activated by the influenza epitope but not vice versa,
questioning the relevance of heterologous immunity against
this epitope (7). Importantly, by using the previously described
combination of tetramer staining, magnetic-bead enrichment,
and multiparametric flow cytometry (1), we were able to detect
naïve HCV-specific CD8 T cells in all seven healthy donors
(Fig. 1). Although the cells were not detectable before the
enrichment step, they could be clearly identified after enrich-
ment, as shown for one representative subject in Fig. 1A. The
cells displayed a naïve phenotype characterized by high expres-
sion of CD45RA, CD27, and CCR7 and low expression of
CD11a (Fig. 1B). Of note, the median calculated precursor
frequency of NS31406 epitope-specific CD8
 T cells was 1.47 
105, and thus 10-fold higher than the calculated precursor
frequencies of CD8 T cells specific for NS5B2594 (5.12 
107) and the Core132 epitope (5.46  10
7) (Fig. 1C). Inter-
estingly, the frequently recognized HLA-A2-restricted NS31073
epitope displayed similar precursor frequencies (5.06  106)
compared to NS31406 (data not shown). Since CD8
 T cell
* Corresponding author. Mailing address: University Hospital
Freiburg, Department of Medicine II, Hugstetter Str. 55, 79106
Freiburg, Germany. Phone: 49-761-270-3280. Fax: 49-761-270-3725.
E-mail: robert.thimme@uniklinik-freiburg.de.
 Published ahead of print on 2 March 2011.
5232
 o
n
 February 25, 2014 by Cardiff Univ
http://jvi.asm.org/
D
ow
nloaded from
 
responses to this epitope were suggested to be influenced by
past exposure to influenza virus by some studies, as discussed
above, we did not analyze this epitope in our further experi-
ments. Although precursor frequencies varied significantly be-
tween epitopes, frequencies for each of the specific epitopes
were conserved across the healthy donors tested. These results
suggest that a clear hierarchy of naïve HCV-specific CD8 T
cell precursor frequencies exists in healthy donors.
Immunodominance of HLA-A2-restricted hepatitis C virus-
specific CD8 T cell responses during chronic infection. Next,
we set out to determine whether the clear hierarchy of naïve-
precursor frequencies for these three epitopes might be linked
to their relative immunodominance in chronically HCV-in-
fected patients. For this purpose, we performed ex vivo tet-
ramer analyses in a prospectively and randomly recruited co-
hort of patients with chronic HCV genotype 1 infection (n 
26). As shown in Fig. 2A and B, we observed clear patterns of
immunodominance, with most responses targeting the NS31406
epitope (8/26 patients), followed by the NS5B2594 epitope (2/26
patients) and finally the Core132 epitope (0/18 patients). Im-
portantly, the same immunodominance profile was also detect-
able after 2 weeks of antigen-specific stimulation. Accordingly,
as shown in Fig. 2C and D, most expanded responses targeted
the NS31406 epitope (8/20 patients), while substantially fewer
responses targeted the NS5B2594 (4/20 patients) and Core132
(1/19 patients) epitopes. Although NS31406 epitope-specific
CD8 T cell responses were not detectable in all patients,
these results indicate a clear immunodominance hierarchy with
respect to these three epitopes. Notably, these results are in
agreement with previous studies of HLA-A2 patients with
chronic HCV infection, in which NS31406 has been shown to be
recognized more frequently than NS5B2594. For example,
Spangenberg et al. (21), Lechner et al. (13), and Racanelli et
al. (19) found NS31406 epitope-specific responses in 8/27, 5/19,
and 5/20 chronically HCV-infected HLA-A2 patients, respec-
tively; in contrast, NS5B2594 epitope-specific responses were
observed in 7/27, 0/10, and 3/20 patients, respectively. It is also
notable that the Core132 epitope was rarely targeted in most
studies (5, 11–13, 21).
Expansion capability and antiviral efficacy of naïve HCV-
specific CD8 T cells is linked to precursor frequency. Since
the immunodominance of the NS31406 epitope in chronically
HCV-infected patients was present not only ex vivo but also
after antigen-specific expansion in vitro, we next asked whether
naïve CD8 T cells would also be able to proliferate after
antigen-specific stimulation and whether expansion capability
could be linked to naïve-precursor frequency. For these exper-
iments, we cocultured enriched CD8 T cells derived from
healthy donors for 12 days with mature autologous dendritic
cells (DCs) pulsed separately with each of the three HLA-A2-
restricted HCV peptides. As shown in Fig. 3A (data are for one
representative patient), the number of NS31406 epitope-spe-
cific CD8 T cells expanded in vitro. Peptide-specific stimula-
tion and expansion led to downregulation of CD45RA and
CCR7 and to upregulation of CD11a, indicating that these
FIG. 1. Enrichment and enumeration of naïve HCV-specific CD8
T cells from healthy donors (n 7). (A) Representative flow cytometry
plots of peripheral blood mononuclear cells (PBMCs) from a healthy
donor showing staining with the NS31406 HLA-A*0201 tetramer before
and after magnetic-bead enrichment. Procedural details are similar to
those described by Alanio et al. (1). In brief, PBMCs were incubated
with FcR blocking reagent and then stained with pMHCI tetramer
labeled with allophycocyanin (APC). Subsequently, labeled cells were
incubated with anti-APC microbeads and passed over a magnetically
activated column. The percentage of tetramer-positive CD8 T cells is
indicated before and after enrichment. (B) Representative phenotypic
analysis of enriched tetramer-positive CD8 T cells. Enriched tet-
ramer-positive CD8 T cells (shown in black) were stained for CD3,
CD45RA, CCR7, CD27, and CD11a; a naïve phenotype (CD45RAhi
CCR7hi CD27hi CD11alow) was apparent in all cases. For reference,
bulk CD8 T cells are shown in gray. (C) Precursor frequencies of
CD8 T cells specific for NS31406, NS5B2594 and Core132 detected in
healthy donors after tetramer staining, magnetic-bead enrichment, and
multiparametric flow cytometry analysis (n  7; one donor was not
tested for Core132). The total number of phenotypically naïve te-
tramer-positive CD8 T cells (Tet) relative to the total number of
CD8 T cells is indicated. A calculation similar to that of Alanio et al.
(1) was used.
TABLE 1. HLA-A2-restricted epitopes
Epitopea Peptide length Sequence IC50 (nM)b
Core132 9 DLMGYIPLV 14.5
NS31406 10 KLVALGINAV 52.8
NS5B2594 9 ALYDVVTKL 11.8
a The subscript numerals indicate the amino acid positions.
b IC50, 50% inhibitory concentration, determined using the Immune Epitope
Database (IEDB http://www.iedb.org).
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cells lost their naïve phenotype and acquired an effector-mem-
ory phenotype (Fig. 3B). Figure 3C summarizes the results
derived from seven healthy donors. Of note, we were able to
expand the pool of naïve NS31406 epitope-specific CD8
 T
cells in 5/7 cases. In contrast, expansion of NS5B2594 and
Core132 epitope-specific CD8
 T cells was barely detectable.
Nevertheless, using higher numbers of enriched CD8 T cells
in the assay, we were able to expand the population of
NS5B2594-specific CD8
 T cells. This indicates that NS5B2594-
specific CD8 T cells exist in naïve individuals and confirms
the biological relevance of low precursor frequencies detected
ex vivo (data not shown). To further confirm the functionality
and specificity of these expanded HCV-specific CD8 T cell
populations, we also analyzed their antiviral efficacy. For these
experiments, HuH7 cells that were transduced with a JFH1-
based selectable subgenomic luciferase replicon and with the
HLA-A*0201 gene (HuH7A2HCV cells) were pulsed sepa-
rately with each of the three HCV epitopes. Subsequently,
these cells were cocultured for 48 h with HCV-specific CD8
T cells previously expanded from the blood of healthy donors.
Importantly, as shown in Fig. 3D, only the expanded NS31406
epitope-specific CD8 T cells were able to significantly inhibit
HCV replication, as measured by luciferase activity. This effect
was lost when the NS31406 epitope-specific CD8
 T cells were
depleted from the expanded cell pool, clearly indicating that
these cells mediated the observed antiviral efficacy.
In summary, the results of this study show for the first time
that CD8 T cell immunodominance hierarchies observed in a
chronic human viral infection such as HCV infection can be
linked to naïve-precursor frequency. Indeed, the NS31406
epitope, for which the highest naïve CD8 T cell precursor
frequencies were consistently identified, was also the most
frequently targeted of the three epitopes in chronically HCV-
infected patients. Although a causal link cannot be proven in
the human setting, it is interesting that these results are in
agreement with a series of elegant mouse studies that support
the important role of naïve T cell frequency as a determinant
of T cell immunodominance (8, 16, 18). However, other fac-
tors, such as antigen abundance, processing efficiency, and
HLA binding affinity, can also influence immunodominance. In
this context, it is noteworthy that the three epitopes analyzed
here display comparable HLA-A2 binding affinities (Table 1).
Another factor that might influence immunodominance in vi-
ral infections is the degree of epitope sequence conservation.
FIG. 2. Immunodominance patterns of HLA-A2-restricted HCV-specific CD8 T cell responses in patients with chronic HCV genotype 1
infection (n  26). (A) Representative ex vivo staining of PBMCs from a chronically HCV-infected patient with NS31406, NS5B2594, and Core132
HLA-A*0201 tetramers. (B) Ex vivo frequencies of CD8 T cells specific for the NS31406, NS5B2594, and Core132 epitopes defined by staining with
the corresponding HLA-A*0201 tetramers; responses were identified in 8/26, 2/26, and 0/18 patients, respectively (cutoff, 0.01% tetramer-positive
CD8 cells). (C) Representative staining with NS31406, NS5B2594, and Core132 HLA-A*0201 tetramers of PBMCs from the patient shown in panel
A after antigen-specific stimulation for 2 weeks as described previously (17). (D) Frequencies of CD8 T cells specific for the NS31406, NS5B2594,
and Core132 epitopes defined by staining with the corresponding HLA-A*0201 tetramers after 2 weeks of antigen stimulation; responses were
identified in 8/20, 4/20, and 1/19 patients, respectively (cutoff, 0.1% tetramer-positive CD8 cells).
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Interestingly, the epitope with the highest naïve CD8 T cell
precursor frequency also displays the highest degree of se-
quence diversity in HCV genotype 1-infected patients (http:
//hcv.lanl.gov [9]), providing one possible explanation for why
this epitope is not targeted in all chronically HCV-infected
patients. On the other hand, viral escape mutations within the
epitope could also contribute to the maintenance of the anti-
viral functions of HCV-specific CD8 T cells, which otherwise
can undergo exhaustion and lose their antiviral functionality
(3, 6). Of note, naïve-precursor frequency also seems to be
associated with the expansion capability of virus-specific CD8
T cells. Indeed, NS31406 epitope-specific CD8
 T cell re-
sponses were dominant in cultures from healthy donors and
chronically HCV-infected patients after in vitro stimulation.
Thus, HLA-A2-restricted HCV-specific CD8 T cell immu-
nodominance appears to be a predetermined feature of the
naïve CD8 T cell repertoire that is relatively independent of
virological factors. These findings may have implications for
vaccine development and adoptive T cell therapy, both of
which require the generation of functionally active virus-spe-
cific CD8 T cells from the naïve pool of antigen-specific
precursors (2, 14–15).
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